Pharmacist-Patient RelationsNCT05580757
Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
An observational study of Pharmacist-Patient Relations and Suicide, run by University Ghent at 1 site in Belgium.
Trial summary
This study aims to examine the opinions and needs of pharmacists and pharmaceutical technical assistants (FTA) concerning their role as gatekeepers in suicide prevention. The primary objective is to map the experiences and needs of (public) pharmacists and FTA with regard to suicide prevention. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Pharmacist-Patient Relations, Suicide, Suicide, Attempted
- How many people
- 118 participants
- Where
- 1 siteBelgium
- Study dates
- 2 Sep 2022to 8 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Dutch-speaking Belgian public pharmacists or pharmaceutical technical assistants (FTA)
Who may be able to join
- Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)
- 18 years or older
- Access to a computer, tablet or mobile phone with internet access
- Dutch-speaking
Who cannot join
- Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.
Trial locations and contacts
1 site in 1 country.
Belgium1 site
Flemish Centre of Expertise in Suicide Prevention, Ghent University
Ghent, 9000
About this study
Official title: Role of Pharmacists in Suicide Prevention: Needs Assessment Among Pharmacists
This study aims to examine the opinions and needs of pharmacists and pharmaceutical technical assistants (FTA) concerning their role as gatekeepers in suicide prevention.
The primary objective is to map the experiences and needs of (public) pharmacists and FTA with regard to suicide prevention.
The secondary objective is to be able to develop more targeted tools, interventions or trainings based on the results of the needs assessment in order to facilitate the role of (public) pharmacists and FTA as gatekeepers in suicide prevention.
- Medical subject headings
- Suicide, Suicide, Attempted, Suicidal Ideation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Pharmacists and pharmaceutical technical assistants (FTA) | Dutch-speaking Belgian public pharmacists or pharmaceutical technical assistants (FTA) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Needs
Questionnaire based on a study by Gillette et al. (2020), scientific literature and previous needs surveys conducted by VLESP. In collaboration with the Flemish Pharmacists Network.
Socio-demographics; Perceptions, attitudes and barriers: 55 statements (completely disagree, disagree, neutral, agree, completely agree); Contact with suicidal person (never/rarely, few times a year, monthly, weekly, daily), experience (very un-, rather un-, neutral, experienced, very experienced), possible actions as gatekeeper, referral, known organizations/helplines, previous education (yes or no), knowledge (yes/no)/ satisfaction (not at all, rather not, neutral, rather, very) existing education; Preparedness/need training (not at all, rather not, neutral, rather, very), preferred format of training, needed information; Suicidal thoughts/attempts (yes/no), hopelessness: 4 items (true/false)
Measured: Baseline. Completing the questionnaire will take approximately 15-20 minutes.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Oct 2022
- Study start2 Sep 2022
- Primary completion8 Dec 2022
- Study completion8 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pharmacist-Patient RelationsStudies of the same condition, open and under way.
- More trials run by University GhentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 118 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gwendolyn Portzky, Phd, Principal investigator, University Ghent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05580757
- Sponsor's protocol ID
- ONZ-2022-0233
- Status last verified
- Jan 2023
- First submitted
- 11 Oct 2022
- Last updated
- 24 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Role of Pharmacists in Suicide Prevention: Needs Assessment Among Pharmacists
- ClinicalTrials.gov ID
- NCT05580757
- Acronym / sponsor ID
- ONZ-2022-0233
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 118 participants (actual)
- Lead sponsor
- University GhentUniversity, hospital or other
- Study start
- 2 Sep 2022 (actual)
- Primary completion
- 8 Dec 2022 (actual)
- Study completion
- 8 Dec 2022 (actual)
- First posted
- 14 Oct 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to examine the opinions and needs of pharmacists and pharmaceutical technical assistants (FTA) concerning their role as gatekeepers in suicide prevention.
The primary objective is to map the experiences and needs of (public) pharmacists and FTA with regard to suicide prevention.
The secondary objective is to be able to develop more targeted tools, interventions or trainings based on the results of the needs assessment in order to facilitate the role of (public) pharmacists and FTA as gatekeepers in suicide prevention.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pharmacists and pharmaceutical technical assistants (FTA) | – | –Dutch-speaking Belgian public pharmacists or pharmaceutical technical assistants (FTA) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Dutch-speaking Belgian public pharmacists or pharmaceutical technical assistants (FTA)
Key inclusion criteria (4 listed)
- Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)
- 18 years or older
- Access to a computer, tablet or mobile phone with internet access
- Dutch-speaking
Key exclusion criteria (1 listed)
- Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Needs
Time frame: Baseline. Completing the questionnaire will take approximately 15-20 minutes.
Questionnaire based on a study by Gillette et al. (2020), scientific literature and previous needs surveys conducted by VLESP. In collaboration with the Flemish Pharmacists Network. Socio-demographics; Perceptions, attitudes and barriers: 55 statements (completely disagree, disagree, neutral, agree, completely agree); Contact with suicidal person (never/rarely, few times a year, monthly, weekly, daily), experience (very un-, rather un-, neutral, experienced, very experienced), possible actions as gatekeeper, referral, known organizations/helplines, previous education (yes or no), knowledge (yes/no)/ satisfaction (not at all, rather not, neutral, rather, very) existing education; Preparedness/need training (not at all, rather not, neutral, rather, very), preferred format of training, needed information; Suicidal thoughts/attempts (yes/no), hopelessness: 4 items (true/false)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Feb 2023.
- Individual participant dataSharing planned: No
Related trials for Pharmacist-Patient Relations
Active, not recruiting
Healthy Opioid Prescription Engagement
Opioid Misuse, Opioid-Related Disorders
Active, not recruiting
Factors Determining the Rate of Adoption of Pharmaceutical Recommendations by Patients in Primary Care Following a Medication Review by a Pharmacist
Polypharmacy (People Under Treatment With 5 or More Drugs), Polypharmacy, Decision-making
Not yet recruiting
A Study to Investigate Health Related Quality of Life With a Pharmacist Intervention Compared to Treatment as Usual in Participants With Severe Mental Illness and Substance Use Disorder Receiving Treatment From FACT Teams.
Severe Mental Illness, Substance Use Disorder (SUD)
Enrolling by invitation
Improving Medication Therapy Through a Digital Interdisciplinary Medicine Therapy Optimisation Model
Medication-related Problems, Self-reported Medication Adherence
Not yet recruitingObservational study
Association Between Geriatric Frailty and Medication Related Problems in the Emergency Department to Help Clinical Pharmacists Prioritise Patients
Frailty, Emergency Department Visit
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gwendolyn Portzky, Phd principal investigator
University Ghent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pharmacist-Patient Relations and Suicide, run by University Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Needs (time frame: Baseline. Completing the questionnaire will take approximately 15-20 minutes.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2023.